Previsioni di mercato per il trattamento dell\'ematuria in Nord America fino al 2028 - Impatto del COVID-19 e analisi regionale per trattamento (farmaci, terapie e altri), indicazione (infezioni del tratto urinario, calcoli renali, uretrite, cancro del sangue, calcoli alla vescica, cancro alla prostata, cistite, traumi) , esercizio fisico intenso, malattia renale policistica, endometriosi e mestruazioni), tipo (ematuria macroscopica, ematuria microscopica, ematuria idiopatica ed ematuria da jogging), utente finale (ospedali, cliniche e centri chirurgici ambulatoriali e altri)
Introduzione al mercato
L\'ematuria è una condizione medica in cui si riscontra la presenza di sangue nelle urine . Generalmente, l\'urina non contiene globuli rossi e quindi ciò può causare problemi seri che possono anche causare calcoli renali, infezioni del tratto urinario e altre malattie ereditarie.
Inoltre, l\'ematuria ad alta prevalenza Si prevede che le indicazioni associate rafforzeranno la crescita del mercato durante il periodo di previsione. Tuttavia, i casi non diagnosticati di indicazioni associate limitano la crescita del mercato del trattamento dell\'ematuria in Nord America.
La pandemia ha offerto opportunità di crescita vitali per gli operatori che operano nel mercato delle malattie renali. Le possibilità erano dovute al crescente numero di pazienti colpiti dal coronavirus. Ad esempio, secondo il rapporto dell’American Society of Nephrology, in risposta al COVID-19, metà dei pazienti positivi al coronavirus ricoverati in unità di terapia intensiva (ICU) sperimentano un’insufficienza renale che richiede una qualche forma di dialisi. Il rapporto affermava che circa dal 10% al 50% dei pazienti in terapia intensiva mostrava insufficienza renale, quasi il 17% dei pazienti necessitava di dialisi urgente e il 46% aveva mostrato alcune forme di danno renale acuto (AKI). In tutta la regione del Nord America, gli Stati Uniti hanno registrato il numero più alto di pazienti colpiti dal coronavirus. Pertanto, un numero crescente di pazienti corre un rischio maggiore di essere colpiti da danno renale acuto (AKI), compreso danno tubulare con shock settico, microinfiammazione, aumento della coagulazione del sangue e probabile infezione diretta del rene. Pertanto, si prevede un aumento della domanda di prodotti per la gestione delle malattie renali che porterà alla crescita del mercato nel prossimo futuro.
Panoramica e dinamiche del mercato
Si prevede che il mercato del trattamento dell\'ematuria in Nord America raggiungerà i 419,7 milioni di dollari entro il 2028 rispetto ai 351,6 milioni di dollari del 2021; si prevede che crescerà a un CAGR del 2,6% dal 2021 al 2028. Gli sviluppi tecnologici nei dispositivi medici e nelle procedure diagnostiche hanno portato a varie opzioni per la gestione delle indicazioni associate all\'ematuria, come calcoli renali, calcoli alla vescica e infezioni del tratto urinario. Si prevede che l’uso di tecnologie di trattamento avanzate migliorerà la cura dei pazienti. Ad esempio, negli ultimi anni ha guadagnato popolarità l’implementazione della robotica negli interventi chirurgici per il trattamento dell’urolitiasi. Attualmente, Vinci Surgical System, di Intuitive Surgical Inc., è ampiamente utilizzato nell\'esecuzione di interventi chirurgici per il trattamento dell\'urolitiasi. Allo stesso modo, la diffusione degli interventi endourologici per i calcoli renali è aumentata in modo significativo in vari paesi. Si prevede inoltre che i progressi nelle indicazioni associate possano sostenere il mercato del trattamento dell\'ematuria in Nord America durante il periodo di previsione.
Segmenti chiave del mercato
In termini di tipologia, il segmento dell\'ematuria macroscopica ha rappresentato la quota maggiore del mercato del trattamento dell\'ematuria in Nord America nel 2020. In termini di trattamento, i farmaci ha rappresentato la quota maggiore del mercato del trattamento dell’ematuria in Nord America nel 2020. In termini di indicazioni, il segmento delle infezioni del tratto urinario ha rappresentato la quota maggiore del mercato del trattamento dell’ematuria in Nord America nel 2020. In termini di utente finale, il segmento degli ospedali ha rappresentato la quota maggiore del mercato del trattamento dell\'ematuria in Nord America nel 2020.
Principali fonti e aziende elencate
Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato del trattamento dell\'ematuria in Nord America sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici. , tra gli altri. Le principali aziende elencate nel rapporto sono AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd e Boehringer Ingelheim International GmbH.
Rapporto sui motivi per acquistare
- Comprendere il panorama del mercato del trattamento dell\'ematuria in Nord America e identificare i segmenti di mercato che probabilmente garantiranno un forte ritorno
- Comprendere il panorama di mercato in continua evoluzione e rimanere all\'avanguardia nella concorrenza
- Per pianificare in modo efficiente fusioni, acquisizioni e accordi di partnership nel mercato del trattamento dell\'ematuria del Nord America identificando i segmenti con le vendite probabili più promettenti
- Prendere decisioni aziendali consapevoli partendo da un\'analisi percettiva e completa di l\'andamento del mercato dei vari segmenti
- Ottenere previsioni sui ricavi del mercato del trattamento dell\'ematuria in Nord America sulla base di vari segmenti per il periodo dal 2021 al 2028
SEGMENTAZIONE DEL MERCATO DEL TRATTAMENTO DELL\'EMATURIA IN NORD AMERICA
Da Trattamento
- Farmaci
- Terapie
- Altro
Per indicazione
- Infezioni del tratto urinario
- Calcoli renali
- Uretrite
- Cancro del sangue
- Calcoli alla vescica
- Cancro alla prostata
- Cistite
- Trauma
- Vigoroso Esercizio fisico
- Malattia renale policistica
- Endometriosi
- Mestruazioni
Per Tipo
- Ematuria macroscopica
- Ematuria microscopica
- Ematuria idiopatica
- Ematuria del pareggiatore
Per utente finale
- Ospedali
- Cliniche
- Centri chirurgici ambulatoriali (ASC)
- Altro
Per Paese
- Nord America
- Stati Uniti
- Canada
- Messico
Aziende citate
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- < span>Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Hematuria Treatment Market – By Treatment
1.3.2 North America Hematuria Treatment Market – By Indication
1.3.3 North America Hematuria Treatment Market – By Type
1.3.4 North America Hematuria Treatment Market – By End User
1.3.5 North America Hematuria Treatment Market – By Country
2. North America Hematuria Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hematuria Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Experts Opinion
5. Hematuria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Hematuria-Associated Indications
5.1.2 Increasing Awareness About Treatment Options and Improving Healthcare Expenditure
5.2 Market Restraints
5.2.1 Undiagnosed Cases of Associated Indications
5.3 Market Opportunities
5.3.1 Increasing Opportunities for Related Treatments
5.4 Future Trends
5.4.1 Rise in Preference for Advanced Therapies
5.5 Impact Analysis
6. Hematuria Treatment Market – North America Analysis
6.1 North America Hematuria Treatment Market Revenue Forecast and Analysis
7. Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment
7.1 Overview
7.2 North America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
7.3 Drugs
7.3.1 Overview
7.3.2 Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Therapies
7.4.1 Overview
7.4.2 Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Others
7.5.1 Overview
7.5.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8. Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication
8.1 Overview
8.2 North America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
8.3 Kidney Stones
8.3.1 Overview
8.3.2 Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Urinary Tract Infections (UTI)
8.4.1 Overview
8.4.2 Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Urethritis
8.5.1 Overview
8.5.2 Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Blood Cancer
8.6.1 Overview
8.6.2 Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Bladder Stones
8.7.1 Overview
8.7.2 Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Prostate Cancer
8.8.1 Overview
8.8.2 Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.9 Cystitis
8.9.1 Overview
8.9.2 Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.10 Trauma
8.10.1 Overview
8.10.2 Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.11 Vigorous Exercise
8.11.1 Overview
8.11.2 Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.12 Polycystic Kidney Disease
8.12.1 Overview
8.12.2 Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.13 Endometriosis
8.13.1 Overview
8.13.2 Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.14 Menstruation
8.14.1 Overview
8.14.2 Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
9. Hematuria Treatment Market Revenue and Forecast To 2028 – By Type
9.1 Overview
9.2 North America Hematuria Treatment Market, By Type 2020 & 2028 (%)
9.3 Macroscopic Hematuria
9.3.1 Overview
9.3.2 Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.4 Microscopic Hematuria
9.4.1 Overview
9.4.2 Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.5 Idiopathic Hematuria
9.5.1 Overview
9.5.2 Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.6 Jogger’s Hematuria
9.6.1 Overview
9.6.2 Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
10. Hematuria Treatment Market Revenue and Forecast To 2028 – By End User
10.1 Overview
10.2 North America Hematuria Treatment Market Share by End User 2020 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Ambulatory Surgical Centers (ASC’s)
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
11. North America Hematuria Treatment Market – Geographic Analysis
11.1 North America: Hematuria Treatment Market
11.1.1 Overview
11.1.2 North America: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
11.1.2.1 US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1 US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.2 US: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.3 US: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.4 US: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.5 US: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.2.2 Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2 Canada: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.3 Canada: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.4 Canada: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.5 Canada: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.2.3 Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1 Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.2 Mexico: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.3 Mexico: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.4 Mexico: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.5 Mexico: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Hematuria Treatment Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. Hematuria Treatment Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 AstraZeneca
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bristol-Myers Squibb Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Janssen Pharmaceuticals
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Boehringer Ingelheim International GmbH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. US: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 2. US: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 3. US: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 4. US: Hematuria Treatment Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 5. Canada: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Hematuria Treatment Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments Done by Companies
Table 14. Inorganic Developments Done by Companies
Table 15. Glossary of Terms, Hematuria Treatment Market
LIST OF FIGURES
Figure 1. Hematuria Treatment Market Segmentation
Figure 2. North America Hematuria Treatment Market Overview
Figure 3. Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market
Figure 4. US to Show Significant Growth During Forecast Period
Figure 5. North America Hematuria Treatment Market, Industry Landscape
Figure 6. North America PEST Analysis
Figure 7. Hematuria Treatment Market Impact Analysis of Drivers and Restraints
Figure 8. North America Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. North America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
Figure 10. Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 11. Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 12. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 13. North America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
Figure 14. Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 15. Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 16. Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 17. Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 18. Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 19. Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 20. Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 21. Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 22. Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 23. Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 24. Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 25. Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 26. North America Hematuria Treatment Market, by Type 2020 & 2028 (%)
Figure 27. Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 28. Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 29. Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 30. Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 31. North America Hematuria Treatment Market Share by End User 2020 & 2028 (%)
Figure 32. Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 33. Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 34. Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 35. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 36. North America: Hematuria Treatment Market, by Key Country – Revenue (2021) (USD Million)
Figure 37. North America: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
Figure 38. US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Impact Of COVID-19 Pandemic in North America Country Markets
Figure 42. Growth Strategies Done by the Companies in the Market, (%)
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America hematuria treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.